HCP Guide for Accessing SAPHNELO (anifrolumab-fnia)
October 20, 2026

This guide is a resource for access and affordability support, tips for getting started, reimbursement information, and your options for SAPHNELO.
To view the Accessing SAPHNELO: A Guide for Healthcare Professionals, click here!
For US Healthcare Professionals
SAPHNELO is a registered trademark of the AstraZeneca group of companies.
©2026 AstraZeneca. All rights reserved. US-109294 Last Updated 8/26